Camp4 Therapeutics Corp
CAMP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001736730
In the last 90 days, Camp4 Therapeutics Corp insiders filed 5 open-market purchases and 4 sales; 61 institutions reported holding it in 13F filings for Q2 2026, worth $182.2M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Camp4 Therapeutics Corp as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 29
- 0 vs. Q2 2025
- Shares held
- 28.2M
- +16.5M (+140.2%) vs. Q2 2025
- Total value
- $84.6M
- +$67.6M (+396.9%) vs. Q2 2025
- New holders
- 8
- 4 more added
- Sold out
- 8
- 10 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CAMP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 61 | $182.2M |
| Q1 2026 | 46 | $175.5M |
| Q4 2025 | 40 | $234.6M |
| Q3 2025 | 29 | $84.6M |
| Q2 2025 | 29 | $17.0M |
| Q1 2025 | 39 | $50.7M |
| Q4 2024 | 36 | $67.1M |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Camp4 Therapeutics Corp; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| CWM, LLC | 5 | $0 | 0.00% | −63−92.6% | Reduced |
| Morgan Stanley | 3 | $9 | 0.00% | −1,684−99.8% | Reduced |
| SBI Securities Co., Ltd. | 15 | $45 | 0.00% | −5−25.0% | Reduced |
| Barclays PLC | 70 | $210 | 0.00% | +70 | New |
| BNP Paribas Arbitrage, SA | 78 | $234 | 0.00% | −349−81.7% | Reduced |
| Bank of America Corp | 283 | $849 | 0.00% | −369−56.6% | Reduced |
| Royal Bank of Canada | 953 | $3.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 5,649 | $16.9K | 0.00% | +1,819+47.5% | Added |
| UBS Group AG | 7,043 | $21.1K | 0.00% | +1,955+38.4% | Added |
| BlackRock, Inc. | 11,437 | $34.3K | 0.00% | −72,784−86.4% | Reduced |
| Northern Trust Corp | 14,615 | $43.8K | 0.00% | 00.0% | Unchanged |
| Mariner, LLC | 17,298 | $51.9K | 0.00% | +17,298 | New |
| Bridgeway Capital Management, LLC | 25,000 | $75.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 26,000 | $78.0K | 0.00% | +26,000 | New |
| Geode Capital Management, LLC | 60,371 | $181.1K | 0.00% | −14,828−19.7% | Reduced |
| Victory Capital Management Inc | 82,790 | $248.4K | 0.00% | −270−0.3% | Reduced |
| Millennium Management LLC | 95,071 | $285.2K | 0.00% | −37,965−28.5% | Reduced |
| Two Sigma Investments, LP | 97,371 | $292.1K | 0.00% | +97,371 | New |
| Alyeska Investment Group, L.P. | 200,000 | $600.0K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 313,506 | $940.5K | 0.00% | −15,385−4.7% | Reduced |
| Silverarc Capital Management, LLC | 653,594 | $1.96M | 0.28% | +653,594 | New |
| HarbourVest Partners LLC | 1,271,948 | $3.82M | 1.86% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 1,960,784 | $5.88M | 0.01% | +1,960,784 | New |
| AH Capital Management, L.L.C. | 2,125,339 | $6.38M | 0.46% | 00.0% | Unchanged |
| FMR LLC | 3,023,434 | $9.07M | 0.00% | +2,415,488+397.3% | Added |
| Enavate Sciences GP, LLC | 3,785,802 | $11.4M | 3.47% | 00.0% | Unchanged |
| Vivo Capital, LLC | 3,921,568 | $11.8M | 0.95% | +3,921,568 | New |
| Janus Henderson Group PLC | 4,640,970 | $13.9M | 0.01% | +4,640,970 | New |
| 5AM Venture Management, LLC | 5,869,091 | $17.6M | 6.45% | +2,941,176+100.5% | Added |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −26,511−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −14,871−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −14,760−100.0% | Sold out |
| Cantor Fitzgerald, L. P. | 0 | $0 | 0.00% | −12,320−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −238−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −119−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −101−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |